Guardant Health (GH) Cash from Investing Activities (2017 - 2026)

Guardant Health has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $101.5 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 1052.89% year-over-year to $101.5 million; the TTM figure through Jun 2026 stood at -$118.5 million (down 1596.92% YoY), while the FY2025 annual figure was -$627.2 million, down 140.02% from the prior year.
• Cash from Investing Activities came in at $101.5 million for Q2 2026 at Guardant Health, down from $699.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $699.4 million in Q1 2026 to a low of -$905.1 million in Q4 2025.
• Average Cash from Investing Activities over 5 years is $50.1 million, with a median of $34.7 million recorded in 2022.
• Year-over-year, Cash from Investing Activities sank 8695.13% in 2025 and soared 1052.89% in 2026.
• Over 5 years, Cash from Investing Activities stood at $70.6 million in 2022, then soared by 839.38% to $663.5 million in 2023, then plunged by 98.41% to $10.5 million in 2024, then slumped by 8695.13% to -$905.1 million in 2025, then soared by 111.21% to $101.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $101.5 million in Q2 2026, $699.4 million in Q1 2026, and -$905.1 million in Q4 2025.